Correlation Between Cabio Biotech and Beijing Ultrapower

Can any of the company-specific risk be diversified away by investing in both Cabio Biotech and Beijing Ultrapower at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cabio Biotech and Beijing Ultrapower into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cabio Biotech Wuhan and Beijing Ultrapower Software, you can compare the effects of market volatilities on Cabio Biotech and Beijing Ultrapower and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cabio Biotech with a short position of Beijing Ultrapower. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cabio Biotech and Beijing Ultrapower.

Diversification Opportunities for Cabio Biotech and Beijing Ultrapower

0.47

Correlation Coefficient

Cabio Biotech  Beijing Ultrapower

Very weak diversification

The 3 months correlation between Cabio and Beijing is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Cabio Biotech Wuhan and Beijing Ultrapower Software in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beijing Ultrapower and Cabio Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cabio Biotech Wuhan are associated (or correlated) with Beijing Ultrapower. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beijing Ultrapower has no effect on the direction of Cabio Biotech i.e., Cabio Biotech and Beijing Ultrapower go up and down completely randomly.

Pair Corralation between Cabio Biotech and Beijing Ultrapower

Assuming the 90 days trading horizon Cabio Biotech Wuhan is expected to generate 1.17 times more return on investment than Beijing Ultrapower. However, Cabio Biotech is 1.17 times more volatile than Beijing Ultrapower Software. It trades about 0.06 of its potential returns per unit of risk. Beijing Ultrapower Software is currently generating about 0.05 per unit of risk. If you would invest  1,381  in Cabio Biotech Wuhan on October 9, 2024 and sell it today you would earn a total of  447.00  from holding Cabio Biotech Wuhan or generate 32.37% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Cabio Biotech Wuhan  vs.  Beijing Ultrapower Software

Cabio Biotech Wuhan

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cabio Biotech Wuhan has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Cabio Biotech is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Beijing Ultrapower

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Beijing Ultrapower Software has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Cabio Biotech and Beijing Ultrapower

The main advantage of trading using opposite Cabio Biotech and Beijing Ultrapower positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cabio Biotech position performs unexpectedly, Beijing Ultrapower can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beijing Ultrapower will offset losses from the drop in Beijing Ultrapower's long position.

The idea behind Cabio Biotech Wuhan and Beijing Ultrapower Software pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.